Clinical Trial Update: A Study of the Effectiveness And Safety Of Lidoderm® As Add-On Treatment in Patients With Postherpetic Neuralgia, Diabetic Neuropathy, or Low Back Pain [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Lidoderm as add-on therapy for postherpetic neuralgia, diabetic neuropathy, or low back pain; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy
• Low Back Pain
• Postherpetic Neuralgia

Drugs mentioned

• Lidoderm (lidocaine patch 5%)

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Postherpetic Neuralgia, Diabetic Neuropathy | Phase 4 | Status: COMPLETED